share_log

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  May 2 15:30
Summary by Moomoo AI
Arcutis Biotherapeutics, Inc. officer Burnett Patrick is set to sell 9,555 shares of common stock on 05/02/2024, as per the latest filing. The shares, valued at an aggregate market value of $83,489, were acquired on 05/01/2024 through a restricted stock vest from Arcutis Biotherapeutics. This transaction follows a previous sale of 4,782 shares by the officer in the past three months, which had gross proceeds of $53,181.
Arcutis Biotherapeutics, Inc. officer Burnett Patrick is set to sell 9,555 shares of common stock on 05/02/2024, as per the latest filing. The shares, valued at an aggregate market value of $83,489, were acquired on 05/01/2024 through a restricted stock vest from Arcutis Biotherapeutics. This transaction follows a previous sale of 4,782 shares by the officer in the past three months, which had gross proceeds of $53,181.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more